Vorwarts Pharma sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-02-21
Share capital
5,000.00 PLN
Activity description

Vorwarts Pharma manufactures dietary supplements in line with international standards and works with leading European producers. Its portfolio includes Betargin, Mamalac, Artizhel, Epiwell, Lorekt and Flomma, covering support for detox, digestion, liver function, immunity, mucous membranes and sleep. The company also handles marketing, distribution and international activity, and produces branded products in GMP-certified plants.

Registered address
ul. Juliana Konstantego Ordona 5D/4, 01-237 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-15171-34496-CCWVD-26

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 432 days for 2020).

  • 202510/06/2026
  • 202416/04/2025
  • 202310/05/2024
  • 202229/05/2023
  • 202121/12/2022
  • 202021/12/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods878 / 1,136
Top 77%
Division · Wholesale trade14,238 / 20,037
Top 71%
City · Warszawa29,452 / 56,729
Top 52%
Voivodeship · Mazowieckie41,076 / 76,892
Top 53%
Country · Poland163,140 / 297,069
Top 55%

Results vs industry

Revenue
This companyUSD 210.14kMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD -254.55kMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 325.82kMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 1.24mMedianUSD 610.11kAverageUSD 11.92m

Websites

The site is available in: Polish, English and Ukrainian.

  • vorwartspharma.plSklep internetowy firmy farmaceutycznej Vorwarts Pharma
    WooCommerceWordPress 6.8Google AnalyticsGoogle Tag ManagerRank MathCloudflare

Trademarks

The company holds 12 active trademarks registered with the Polish Patent Office. 6 applications are pending. 3 marks have expired or were not registered. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
REVITALOSE Z.5713935Protected Jul 2, 2034
FLomma Z.5696035Protected May 16, 2034
evisio Z.5696055Protected May 16, 2034
DŻILLA (word)Z.5676755Protected Mar 26, 2034
EPIWELL (word)Z.5674385Protected Mar 20, 2034
MarkProtected until
REVITALOSE Jul 2, 2034
FLomma May 16, 2034
evisio May 16, 2034
DŻILLA (word)Mar 26, 2034
EPIWELL (word)Mar 20, 2034

Authorized Representatives

Sergii Boiko age 51 – President of the Management Board
Roman Prysiazhniuk age 29 – Attorney-in-fact

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required.

Ownership

OwnerSharesShare valueStake
Mariia Boiko
10$135.0610%
90$1,215.5690%

Sergii Boiko and Mariia Boiko hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-04-07.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Medifar sp. z o.o.
Pharmavene sp. z o.o.
Hauster sp. z o.o. sp. k.
Nexon Pharma sp. z o.o.
KE Pharma Spółka z Ograniczoną Odpowiedzialością sp. z o.o.
Cergopharma sp. z o.o.
PM Pharma sp. z o.o.
A&M Invest sp. z o.o.
Kosma Pharma Group sp. z o.o.
Holistic Poland sp. z o.o.

Change history

DateEvent
2021-06-16PKD change
2020-11-23Address change
2020-11-23PKD change
2018-02-21Entered in the register

FAQ

Last updated: 2026-07-09